Basel
BASEL, Switzerland, September 22, 2011 -
A team of researchers from Roche (SIX: RO, ROG; OTCQX: RHHBY), including scientists from Roche Pharma Research and Early Development and Roche NimbleGen, reported inGenome Research (1) that they have generated the first draft genome sequence of the cynomolgus monkey (Macaca fascicularis) and developed a novel microarray design for in depth expression profiling for use in preclinical drug safety research.
BASEL, Switzerland, September 5, 2011 -
- Cross reference: Picture is available via epa european pressphoto agency
After two years of reconstruction, refurbishment and expansion, the Museum der Kulturen is ready to reopen its doors.
BASEL, Switzerland, July 4, 2011 -
- With Photos
The Swiss photovoltaic specialist TRITEC is now on the UK market
with an own branch office.
BASEL, Switzerland, April 4, 2011 - Jacob & Co.
BASEL, Switzerland, March 24, 2011 - The majority of the direct descendants of company founder
Fritz Hoffmann-La Roche have decided to continue the shareholder pooling
agreement existing since 1948 with a modified shareholder composition.
More News
- Strategic Partnership to Develop and Commercialize a Novel Ophthalmic Self-Diagnostic System for Blood Glucose Monitoring by Diabetes Patients
- NUTRI-FACTS Goes Online! - A New Online Information Source About Vitamins and More
- Crossreference: TRI-KA Specifications can be downloaded at https://www.presseportal.de/pm/75665/ -
- TAG Heuer and Tesla Motors Embark on "Odyssey of Pioneers" World Tour
- 4-Antibody Announces a Long-Term Collaboration With Boehringer Ingelheim for Therapeutic Antibodies
- For Non-US, Non-UK Media Only
- Ilaris(R) Recommended for European Approval as New Biologic Drug to Treat a Rare but Serious Group of Auto-Inflammatory Diseases
- One-Year Phase III Study Confirms Ilaris(R) Offers Long-Term Remission in Patients With CAPS, a Severe Lifelong Auto-Inflammatory Disease
- Phase III Data Show Novartis Investigational Bronchodilator QAB149 Significantly Improves Lung Function Over Current Treatments in COPD[1,2]
- Newly Published Study Shows That Re-Treatment With Pegasys(R) (Peginterferon Alfa-2a) Provides Hepatitis C Patients With a Second Chance for a Cure